Company Filing History:
2 out of 167 
1 out of 4,179 
Years Active: 2013-2014
Title: The Innovative Contributions of Wilfried Homberger
Introduction: Wilfried Homberger, an accomplished inventor based in Ludwigshafen, Germany, has made significant contributions to the field of pharmaceutical science. With a strong background in research and development, he has been granted two patents that showcase his innovative ideas and commitment to advancing medical treatments.
Latest Patents: Homberger’s latest patents include groundbreaking work in the area of benzimidazolone and aminotetraline derivatives. The first patent, titled "Substituted benzimidazolone derivatives, medicaments comprising them and their use," relates to novel benzimidazolone derivatives that aim to treat vasopressin-dependent diseases through specific chemical formulations. The second patent, "Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy," highlights the development of aminotetraline derivatives, which serve as GlyT1 inhibitors. These inventions hold promise for therapeutic applications and exemplify his innovative contributions to medicine.
Career Highlights: Throughout his career, Wilfried Homberger has worked with notable companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and Abbott Laboratories Corporation. His experience with these organizations has enabled him to refine his skills in drug development and patenting processes, leading to his successful invention portfolio.
Collaborations: Homberger has collaborated with esteemed colleagues such as Wilhelm Amberg and Michael Ochse, leveraging their expertise and insights to enhance his research initiatives. These collaborations have not only fostered a culture of innovation but have also contributed to the advancement of pharmaceutical science.
Conclusion: Wilfried Homberger exemplifies the spirit of innovation in the field of pharmaceuticals. His inventions, particularly in the development of benzimidazolone and aminotetraline derivatives, highlight his dedication to improving medical treatments. As an inventor, he continues to inspire future generations in the realms of research and development.